Flagship Closes New $270M Fund For Healthcare and Cleantech Ventures
Summary
“We could have raised even more, but we decided to cut it off and get on with forming a portfolio,” says Noubar Afeyan, CEO and managing partner of Flagship Ventures.Flagship was founded in 2000 and has since built a portfolio of more than 65 companies in the fields of biotech, medical technology, and sustainability.That portfolio includes Agios, for example, a Cambridge, MA-based company that established a $150 million development deal with Celgene last year.One late-stage investment with a happy ending for Flagship was Accuri Cytometers, a Michigan maker of scientific instruments that was bought by New Jersey medical device giant Becton, Dickinson and Company in 2011 for $205 million.Overall, Afeyan says, the vast interest in this latest fund bodes well for companies in biotech, medical technology, and cleantech.